Prevalence of Candida and Its Antifungal Susceptibility In Patients of Urinary Tract Infections
Prevalence of Candida And Its Antifungal Susceptibility In Patients Of UTI
Keywords:
Candiduria, Antifungal susceptibility testingAbstract
Background & Objective: The present study was conducted to assess prevalence of Candida in patients of urinary tract infections. Methods: This retrospective study was carried out over period of 5 months from June 2016 to October 2016 at B.J Medical College, Civil Hospital Ahmedabad, Gujarat. Patients who presented with signs and symptoms of urinary tract infections were included. Urine samples were received from the patients clinically suspected of urinary tract infection. Isolation and identification of pathogen was done by standard microbiological method. Antifungal susceptibility testing for amphotericin-B, itraconazole, clotrimazole, fluconazole was carried out using out standard methods. Result: Out of total 4785 urine samples tested, 168(3.51%) showed growth of Candida species. Out of these 168 positive patient for Candida, 68(40.4%) was positive for Candida albicans,56(33.3%) was positive for Candida tropicalis,10(5.95%) was positive for Candida parapsilosis,27(16%) was positive for Candida krusei,7(4.16%) was positive for Candida dublinensis. The Candida isolates were more susceptible to Amphotericin-B(81.47%) and Itraconazole(60.30%) compared to Clotrimazole(59.60%) and Fluconazole(51.67%). Conclusion: Based on present study there is need to consider candiduria as an important entity in today’s scenario.The presence of candiduria represents therapeutic challenge and should be verified by second clean catch urine culture.It is of utmost importance not only to identify candida species but also to conduct its antifungal profile. [Aarushi A NJIRM 2017; 8(2):44-47]
References
2. Behzadi1 P, Behzadi E, Ranjbar R. Urinary tract infections and Candida albicans. Central European Journal of Urology.2015;68:96-101
3. Yashavanth R, Shiju M.P, Bhaskar U.A, Ronald R, Anita K.B. Candiduria: Prevalence and Trends in Antifungal Susceptibility in A Tertiary Care Hospital of Mangalore. Journal of Clinical and Diagnostic Research. 2013 Nov; Vol-7(11): 2459-24612460
4. Behzadi P,Behzadi E, Hodjjat Yazaanbod. Urinary tract infections associated with Candida albicans. Journal of Medicine. Maedica, Dec 2010:5(4):277-279.
5. Khan P, Nazish F, Nabeela, SarvarJahan, Haris M. Khan and Abida M.Antifungal Susceptibility Pattern of Candida Isolates from a Tertiary Care Hospital of North India: A Five Year Study. International Journal Of Current Microbiology And Applied Sciences,2015;(1): 177-181.
6. Mahmoudabadi ZA, A Rezaei-Matehkolaei, Ghanavati F. The Susceptibility Patterns of Candida Species Isolated From Urine Sample to Posaconazole and Caspofungin. Jundishapur Journal of Microbiology. 2015 March; 8(3): e24298.
7. Ragini A.K., Sandhya Belawadi, Gaytri Devi, Indumal. 2001. Characterisation and antifungal susceptibility testing for Candida in a tertiary care hospital. J. Health Sci. Res., 2(2): 1 12.
8. Joshi.E, Najotra. D, Singh.V. Prevalence and Risk Factors of Nosocomial Candiduria A One Year Prospective Study from a Tertiary Care Centre of Haryana, India.2015;4(10): 402-408.
9. Patel L, Pethani J, Bhatia P, Rathod S, Shah P. Prevalence Of Candida Infection And Its Antifungal Susceptibility Pattern In Tertiary Care Hospital, Ahmedabad. National Journal Of Medical Research. 2012;2(4):439-441.
